Utility of repeat radiofrequency ablation to provide long-term local control in recurrent rectal cancer
Maarten Vermaas(Association of British Orchestras), J. W. Kuiper(University of Konstanz), C. Verhoef(Erasmus MC Cancer Institute), Johannes H.W. de Wilt(Radboud University Nijmegen), A.M.M. Eggermont(Praxis für Hämatologie und Onkologie)
Cited by 4
Related Papers
Final results of the EORTC 18871/DKG 80-1 randomised phase III trial
|European Journal of Cancer|2003|240
Total Pelvic Exenteration for Primary and Recurrent Malignancies
|World Journal of Surgery|2009|193
First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer Group
|The Lancet Oncology|2023|168
Thermal ablation versus surgical resection of small-size colorectal liver metastases (COLLISION): an international, randomised, controlled, phase 3 non-inferiority trial
|The Lancet Oncology|2025|158
Total pelvic exenteration for primary locally advanced and locally recurrent rectal cancer
|European Journal of Surgical Oncology|2006|140